Correlation Between Cingulate and Coherus BioSciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cingulate and Coherus BioSciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate and Coherus BioSciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate and Coherus BioSciences, you can compare the effects of market volatilities on Cingulate and Coherus BioSciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate with a short position of Coherus BioSciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate and Coherus BioSciences.

Diversification Opportunities for Cingulate and Coherus BioSciences

0.79
  Correlation Coefficient

Poor diversification

The 3 months correlation between Cingulate and Coherus is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate and Coherus BioSciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coherus BioSciences and Cingulate is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate are associated (or correlated) with Coherus BioSciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coherus BioSciences has no effect on the direction of Cingulate i.e., Cingulate and Coherus BioSciences go up and down completely randomly.

Pair Corralation between Cingulate and Coherus BioSciences

Given the investment horizon of 90 days Cingulate is expected to generate 4.12 times more return on investment than Coherus BioSciences. However, Cingulate is 4.12 times more volatile than Coherus BioSciences. It trades about 0.01 of its potential returns per unit of risk. Coherus BioSciences is currently generating about -0.06 per unit of risk. If you would invest  9,180  in Cingulate on August 25, 2024 and sell it today you would lose (8,708) from holding Cingulate or give up 94.86% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Cingulate  vs.  Coherus BioSciences

 Performance 
       Timeline  
Cingulate 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cingulate has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Coherus BioSciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Coherus BioSciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Cingulate and Coherus BioSciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cingulate and Coherus BioSciences

The main advantage of trading using opposite Cingulate and Coherus BioSciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate position performs unexpectedly, Coherus BioSciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coherus BioSciences will offset losses from the drop in Coherus BioSciences' long position.
The idea behind Cingulate and Coherus BioSciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges